# [[Antibiotic/ja|抗生物質]]: [[Microorganism/ja|細菌]]の繁殖阻害
* 診断薬: [[topical anesthetic/ja|局所麻酔薬]]、 [[sympathomimetic/ja|交感神経刺激薬]]、 [[parasympatholytic/
...
58 KB (1,845 words) - 17:09, 5 November 2023
# [[Antibiotic|Antibiotic]]s: inhibiting [[Microorganism|germ]] growth
* Diagnostic: [[topical anesthetic|topical anesthetic]]s, [[sympathomimetic|sympathomimetic]]s, [[parasympatholytic|pa
...
52 KB (6,923 words) - 17:09, 5 November 2023
# [[Antibiotic|Antibiotic]]s: inhibiting [[Microorganism|germ]] growth
* Diagnostic: [[topical anesthetic|topical anesthetic]]s, [[sympathomimetic|sympathomimetic]]s, [[parasympatholytic|pa
...
54 KB (7,245 words) - 17:08, 5 November 2023
...て、または食事もしくは食事の唯一の項目として使用するために表示されたものであってはならない。さらに、栄養補助食品は、新[[drug/ja|薬]]、[[antibiotic/ja|抗生物質]]、生物学的製剤として承認または調査認可されることはできない。DSHEAの下では、栄養補助食品は薬物の定義の目的を除き、食品とみなされ
.../ja|医薬品]]ではないものによって定義される。[[nasal spray/ja|鼻腔スプレー]]として、あるいはローションとして皮膚に塗布する[[Topical medication/ja|局所的]]な使用を目的とした製品は、その資格がない。FDA認可の薬物を栄養補助食品の原材料とすることはできない。サプリメン
...
53 KB (1,344 words) - 20:01, 6 April 2024
...her therapy.<ref name="Nurs2015" /> This can include medications such as [[antibiotic]]s, [[immunoglobulin]], and [[hormone]]s such as testosterone and [[medroxy
...arily more invasive than other forms of administration such as by mouth or topical and require training to perform appropriately, without which complications
...
29 KB (4,153 words) - 17:21, 3 January 2023
...modified to both increase the production of riboflavin and to introduce an antibiotic ([[ampicillin]]) resistance marker, is employed at a commercial scale to pr
...al stiffness. Cross-linking is achieved by applying a [[topical medication|topical]] riboflavin solution to the cornea, which is then exposed to [[Ultraviolet
...
32 KB (4,510 words) - 16:27, 19 February 2024
...modified to both increase the production of riboflavin and to introduce an antibiotic ([[ampicillin]]) resistance marker, is employed at a commercial scale to pr
...al stiffness. Cross-linking is achieved by applying a [[topical medication|topical]] riboflavin solution to the cornea, which is then exposed to [[Ultraviolet
...
33 KB (4,610 words) - 16:27, 19 February 2024
...nt cannot be approved or authorized for investigation as a new [[drug]], [[antibiotic]], or biologic, unless it was marketed as a food or a dietary supplement be
...armaceutical drugs]]. Products intended for use as a [[nasal spray]], or [[Topical medication|topically]], as a lotion applied to the skin, do not qualify. FD
...
43 KB (6,265 words) - 18:52, 7 November 2023
...nt cannot be approved or authorized for investigation as a new [[drug]], [[antibiotic]], or biologic, unless it was marketed as a food or a dietary supplement be
...armaceutical drugs]]. Products intended for use as a [[nasal spray]], or [[Topical medication|topically]], as a lotion applied to the skin, do not qualify. FD
...
44 KB (6,413 words) - 18:53, 7 November 2023
...uter A, Saller R, Melzer J | title = Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study | jour
...erred species for use are ''Cyp. parviflorum'' and ''Cyp.acaule'', used as topical applications or tea.<ref>{{cite book|last=Cichoke|first=Anthony J| name-lis
...
114 KB (14,880 words) - 23:34, 3 January 2023
...switched to an oral form is sometimes considered when choosing appropriate antibiotic therapy for use in a hospital setting, as a person is unlikely to be discha
To reduce pain associated with the procedure, medical staff may apply a topical local anaesthetic (such as [[EMLA]] or [[tetracaine|Ametop]]) to the skin o
...
60 KB (8,656 words) - 17:20, 3 January 2023